世界のボツリヌス中毒治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Botulism Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0961
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、ボツリヌス中毒治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗毒素、抗生物質、その他）、用途別市場規模（病院・クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・ボツリヌス中毒治療の市場動向
・企業の競争状況、市場シェア
・ボツリヌス中毒治療の種類別市場規模（抗毒素、抗生物質、その他）
・ボツリヌス中毒治療の用途別市場規模（病院・クリニック、その他）
・ボツリヌス中毒治療の北米市場規模2016-2027（アメリカ、カナダ）
・ボツリヌス中毒治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・ボツリヌス中毒治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ボツリヌス中毒治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ボツリヌス中毒治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（XOMA (U.S.)、Microbiotix (U.S.)、Valeant Pharmaceuticals (Canada)、Morphotek (U.S.)、Medytox Solutions (U.S.)、Lanzhou Institute of Biological Products (China)、Mentor Corporation and Metabiologics (U.S.)、Merz Pharma (Germany)、Allergan (Irish)、Galderma (Switzerland)）
・結論

Botulism is a type of poisoning or infection caused by certain bacteria on the preserved food material.
The overall botulism market also provides a detailed analysis of the type and treatment in various regions which includes Americas, Europe, Asia Pacific and Rest of the World. Americas lead the botulism market owing to the largest number of botulism cases every year.

Market Analysis and Insights: Global Botulism Treatment Market
The global Botulism Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Botulism Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Botulism Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Botulism Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Botulism Treatment market.

Global Botulism Treatment Scope and Market Size
Botulism Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Botulism Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antitoxin
Antibiotics
Others

Segment by Application
Hospitals and Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
XOMA (U.S.)
Microbiotix (U.S.)
Valeant Pharmaceuticals (Canada)
Morphotek (U.S.)
Medytox Solutions (U.S.)
Lanzhou Institute of Biological Products (China)
Mentor Corporation and Metabiologics (U.S.)
Merz Pharma (Germany)
Allergan (Irish)

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Botulism Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antitoxin
1.2.3 Antibiotics
1.2.4 Others
1.3 Market by Application
1.3.1 Global Botulism Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Botulism Treatment Market Perspective (2016-2027)
2.2 Botulism Treatment Growth Trends by Regions
2.2.1 Botulism Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Botulism Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Botulism Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Botulism Treatment Industry Dynamic
2.3.1 Botulism Treatment Market Trends
2.3.2 Botulism Treatment Market Drivers
2.3.3 Botulism Treatment Market Challenges
2.3.4 Botulism Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Botulism Treatment Players by Revenue
3.1.1 Global Top Botulism Treatment Players by Revenue (2016-2021)
3.1.2 Global Botulism Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Botulism Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Botulism Treatment Revenue
3.4 Global Botulism Treatment Market Concentration Ratio
3.4.1 Global Botulism Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Botulism Treatment Revenue in 2020
3.5 Botulism Treatment Key Players Head office and Area Served
3.6 Key Players Botulism Treatment Product Solution and Service
3.7 Date of Enter into Botulism Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Botulism Treatment Breakdown Data by Type
4.1 Global Botulism Treatment Historic Market Size by Type (2016-2021)
4.2 Global Botulism Treatment Forecasted Market Size by Type (2022-2027)

5 Botulism Treatment Breakdown Data by Application
5.1 Global Botulism Treatment Historic Market Size by Application (2016-2021)
5.2 Global Botulism Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Botulism Treatment Market Size (2016-2027)
6.2 North America Botulism Treatment Market Size by Type
6.2.1 North America Botulism Treatment Market Size by Type (2016-2021)
6.2.2 North America Botulism Treatment Market Size by Type (2022-2027)
6.2.3 North America Botulism Treatment Market Size by Type (2016-2027)
6.3 North America Botulism Treatment Market Size by Application
6.3.1 North America Botulism Treatment Market Size by Application (2016-2021)
6.3.2 North America Botulism Treatment Market Size by Application (2022-2027)
6.3.3 North America Botulism Treatment Market Size by Application (2016-2027)
6.4 North America Botulism Treatment Market Size by Country
6.4.1 North America Botulism Treatment Market Size by Country (2016-2021)
6.4.2 North America Botulism Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Botulism Treatment Market Size (2016-2027)
7.2 Europe Botulism Treatment Market Size by Type
7.2.1 Europe Botulism Treatment Market Size by Type (2016-2021)
7.2.2 Europe Botulism Treatment Market Size by Type (2022-2027)
7.2.3 Europe Botulism Treatment Market Size by Type (2016-2027)
7.3 Europe Botulism Treatment Market Size by Application
7.3.1 Europe Botulism Treatment Market Size by Application (2016-2021)
7.3.2 Europe Botulism Treatment Market Size by Application (2022-2027)
7.3.3 Europe Botulism Treatment Market Size by Application (2016-2027)
7.4 Europe Botulism Treatment Market Size by Country
7.4.1 Europe Botulism Treatment Market Size by Country (2016-2021)
7.4.2 Europe Botulism Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Botulism Treatment Market Size (2016-2027)
8.2 Asia-Pacific Botulism Treatment Market Size by Type
8.2.1 Asia-Pacific Botulism Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Botulism Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Botulism Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Botulism Treatment Market Size by Application
8.3.1 Asia-Pacific Botulism Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Botulism Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Botulism Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Botulism Treatment Market Size by Region
8.4.1 Asia-Pacific Botulism Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Botulism Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Botulism Treatment Market Size (2016-2027)
9.2 Latin America Botulism Treatment Market Size by Type
9.2.1 Latin America Botulism Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Botulism Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Botulism Treatment Market Size by Type (2016-2027)
9.3 Latin America Botulism Treatment Market Size by Application
9.3.1 Latin America Botulism Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Botulism Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Botulism Treatment Market Size by Application (2016-2027)
9.4 Latin America Botulism Treatment Market Size by Country
9.4.1 Latin America Botulism Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Botulism Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Botulism Treatment Market Size (2016-2027)
10.2 Middle East & Africa Botulism Treatment Market Size by Type
10.2.1 Middle East & Africa Botulism Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Botulism Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Botulism Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Botulism Treatment Market Size by Application
10.3.1 Middle East & Africa Botulism Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Botulism Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Botulism Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Botulism Treatment Market Size by Country
10.4.1 Middle East & Africa Botulism Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Botulism Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 XOMA (U.S.)
11.1.1 XOMA (U.S.) Company Details
11.1.2 XOMA (U.S.) Business Overview
11.1.3 XOMA (U.S.) Botulism Treatment Introduction
11.1.4 XOMA (U.S.) Revenue in Botulism Treatment Business (2016-2021)
11.1.5 XOMA (U.S.) Recent Development
11.2 Microbiotix (U.S.)
11.2.1 Microbiotix (U.S.) Company Details
11.2.2 Microbiotix (U.S.) Business Overview
11.2.3 Microbiotix (U.S.) Botulism Treatment Introduction
11.2.4 Microbiotix (U.S.) Revenue in Botulism Treatment Business (2016-2021)
11.2.5 Microbiotix (U.S.) Recent Development
11.3 Valeant Pharmaceuticals (Canada)
11.3.1 Valeant Pharmaceuticals (Canada) Company Details
11.3.2 Valeant Pharmaceuticals (Canada) Business Overview
11.3.3 Valeant Pharmaceuticals (Canada) Botulism Treatment Introduction
11.3.4 Valeant Pharmaceuticals (Canada) Revenue in Botulism Treatment Business (2016-2021)
11.3.5 Valeant Pharmaceuticals (Canada) Recent Development
11.4 Morphotek (U.S.)
11.4.1 Morphotek (U.S.) Company Details
11.4.2 Morphotek (U.S.) Business Overview
11.4.3 Morphotek (U.S.) Botulism Treatment Introduction
11.4.4 Morphotek (U.S.) Revenue in Botulism Treatment Business (2016-2021)
11.4.5 Morphotek (U.S.) Recent Development
11.5 Medytox Solutions (U.S.)
11.5.1 Medytox Solutions (U.S.) Company Details
11.5.2 Medytox Solutions (U.S.) Business Overview
11.5.3 Medytox Solutions (U.S.) Botulism Treatment Introduction
11.5.4 Medytox Solutions (U.S.) Revenue in Botulism Treatment Business (2016-2021)
11.5.5 Medytox Solutions (U.S.) Recent Development
11.6 Lanzhou Institute of Biological Products (China)
11.6.1 Lanzhou Institute of Biological Products (China) Company Details
11.6.2 Lanzhou Institute of Biological Products (China) Business Overview
11.6.3 Lanzhou Institute of Biological Products (China) Botulism Treatment Introduction
11.6.4 Lanzhou Institute of Biological Products (China) Revenue in Botulism Treatment Business (2016-2021)
11.6.5 Lanzhou Institute of Biological Products (China) Recent Development
11.7 Mentor Corporation and Metabiologics (U.S.)
11.7.1 Mentor Corporation and Metabiologics (U.S.) Company Details
11.7.2 Mentor Corporation and Metabiologics (U.S.) Business Overview
11.7.3 Mentor Corporation and Metabiologics (U.S.) Botulism Treatment Introduction
11.7.4 Mentor Corporation and Metabiologics (U.S.) Revenue in Botulism Treatment Business (2016-2021)
11.7.5 Mentor Corporation and Metabiologics (U.S.) Recent Development
11.8 Merz Pharma (Germany)
11.8.1 Merz Pharma (Germany) Company Details
11.8.2 Merz Pharma (Germany) Business Overview
11.8.3 Merz Pharma (Germany) Botulism Treatment Introduction
11.8.4 Merz Pharma (Germany) Revenue in Botulism Treatment Business (2016-2021)
11.8.5 Merz Pharma (Germany) Recent Development
11.9 Allergan (Irish)
11.9.1 Allergan (Irish) Company Details
11.9.2 Allergan (Irish) Business Overview
11.9.3 Allergan (Irish) Botulism Treatment Introduction
11.9.4 Allergan (Irish) Revenue in Botulism Treatment Business (2016-2021)
11.9.5 Allergan (Irish) Recent Development
11.10 Galderma (Switzerland)
11.10.1 Galderma (Switzerland) Company Details
11.10.2 Galderma (Switzerland) Business Overview
11.10.3 Galderma (Switzerland) Botulism Treatment Introduction
11.10.4 Galderma (Switzerland) Revenue in Botulism Treatment Business (2016-2021)
11.10.5 Galderma (Switzerland) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Botulism Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antitoxin
Table 3. Key Players of Antibiotics
Table 4. Key Players of Others
Table 5. Global Botulism Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Botulism Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Botulism Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Botulism Treatment Market Share by Regions (2016-2021)
Table 9. Global Botulism Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Botulism Treatment Market Share by Regions (2022-2027)
Table 11. Botulism Treatment Market Trends
Table 12. Botulism Treatment Market Drivers
Table 13. Botulism Treatment Market Challenges
Table 14. Botulism Treatment Market Restraints
Table 15. Global Botulism Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Botulism Treatment Market Share by Players (2016-2021)
Table 17. Global Top Botulism Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botulism Treatment as of 2020)
Table 18. Ranking of Global Top Botulism Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Botulism Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Botulism Treatment Product Solution and Service
Table 22. Date of Enter into Botulism Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Botulism Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Botulism Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Botulism Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Botulism Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Botulism Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Botulism Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Botulism Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Botulism Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Botulism Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Botulism Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Botulism Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Botulism Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Botulism Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Botulism Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Botulism Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Botulism Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Botulism Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Botulism Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Botulism Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Botulism Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Botulism Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Botulism Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Botulism Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Botulism Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Botulism Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Botulism Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Botulism Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Botulism Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Botulism Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Botulism Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Botulism Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Botulism Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Botulism Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Botulism Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Botulism Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Botulism Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Botulism Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Botulism Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. XOMA (U.S.) Company Details
Table 63. XOMA (U.S.) Business Overview
Table 64. XOMA (U.S.) Botulism Treatment Product
Table 65. XOMA (U.S.) Revenue in Botulism Treatment Business (2016-2021) & (US$ Million)
Table 66. XOMA (U.S.) Recent Development
Table 67. Microbiotix (U.S.) Company Details
Table 68. Microbiotix (U.S.) Business Overview
Table 69. Microbiotix (U.S.) Botulism Treatment Product
Table 70. Microbiotix (U.S.) Revenue in Botulism Treatment Business (2016-2021) & (US$ Million)
Table 71. Microbiotix (U.S.) Recent Development
Table 72. Valeant Pharmaceuticals (Canada) Company Details
Table 73. Valeant Pharmaceuticals (Canada) Business Overview
Table 74. Valeant Pharmaceuticals (Canada) Botulism Treatment Product
Table 75. Valeant Pharmaceuticals (Canada) Revenue in Botulism Treatment Business (2016-2021) & (US$ Million)
Table 76. Valeant Pharmaceuticals (Canada) Recent Development
Table 77. Morphotek (U.S.) Company Details
Table 78. Morphotek (U.S.) Business Overview
Table 79. Morphotek (U.S.) Botulism Treatment Product
Table 80. Morphotek (U.S.) Revenue in Botulism Treatment Business (2016-2021) & (US$ Million)
Table 81. Morphotek (U.S.) Recent Development
Table 82. Medytox Solutions (U.S.) Company Details
Table 83. Medytox Solutions (U.S.) Business Overview
Table 84. Medytox Solutions (U.S.) Botulism Treatment Product
Table 85. Medytox Solutions (U.S.) Revenue in Botulism Treatment Business (2016-2021) & (US$ Million)
Table 86. Medytox Solutions (U.S.) Recent Development
Table 87. Lanzhou Institute of Biological Products (China) Company Details
Table 88. Lanzhou Institute of Biological Products (China) Business Overview
Table 89. Lanzhou Institute of Biological Products (China) Botulism Treatment Product
Table 90. Lanzhou Institute of Biological Products (China) Revenue in Botulism Treatment Business (2016-2021) & (US$ Million)
Table 91. Lanzhou Institute of Biological Products (China) Recent Development
Table 92. Mentor Corporation and Metabiologics (U.S.) Company Details
Table 93. Mentor Corporation and Metabiologics (U.S.) Business Overview
Table 94. Mentor Corporation and Metabiologics (U.S.) Botulism Treatment Product
Table 95. Mentor Corporation and Metabiologics (U.S.) Revenue in Botulism Treatment Business (2016-2021) & (US$ Million)
Table 96. Mentor Corporation and Metabiologics (U.S.) Recent Development
Table 97. Merz Pharma (Germany) Company Details
Table 98. Merz Pharma (Germany) Business Overview
Table 99. Merz Pharma (Germany) Revenue in Botulism Treatment Business (2016-2021) & (US$ Million)
Table 100. Merz Pharma (Germany) Recent Development
Table 101. Allergan (Irish) Company Details
Table 102. Allergan (Irish) Business Overview
Table 103. Allergan (Irish) Botulism Treatment Product
Table 104. Allergan (Irish) Revenue in Botulism Treatment Business (2016-2021) & (US$ Million)
Table 105. Allergan (Irish) Recent Development
Table 106. Galderma (Switzerland) Company Details
Table 107. Galderma (Switzerland) Business Overview
Table 108. Galderma (Switzerland) Botulism Treatment Product
Table 109. Galderma (Switzerland) Revenue in Botulism Treatment Business (2016-2021) & (US$ Million)
Table 110. Galderma (Switzerland) Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Botulism Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antitoxin Features
Figure 3. Antibiotics Features
Figure 4. Others Features
Figure 5. Global Botulism Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals and Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Botulism Treatment Report Years Considered
Figure 9. Global Botulism Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Botulism Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Botulism Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Botulism Treatment Market Share by Regions (2022-2027)
Figure 13. Global Botulism Treatment Market Share by Players in 2020
Figure 14. Global Top Botulism Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botulism Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Botulism Treatment Revenue in 2020
Figure 16. Global Botulism Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Botulism Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Botulism Treatment Market Share by Type (2016-2027)
Figure 20. North America Botulism Treatment Market Share by Application (2016-2027)
Figure 21. North America Botulism Treatment Market Share by Country (2016-2027)
Figure 22. United States Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Botulism Treatment Market Share by Type (2016-2027)
Figure 26. Europe Botulism Treatment Market Share by Application (2016-2027)
Figure 27. Europe Botulism Treatment Market Share by Country (2016-2027)
Figure 28. Germany Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Botulism Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Botulism Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Botulism Treatment Market Share by Region (2016-2027)
Figure 38. China Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Botulism Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Botulism Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Botulism Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Botulism Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Botulism Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Botulism Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Botulism Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. XOMA (U.S.) Revenue Growth Rate in Botulism Treatment Business (2016-2021)
Figure 58. Microbiotix (U.S.) Revenue Growth Rate in Botulism Treatment Business (2016-2021)
Figure 59. Valeant Pharmaceuticals (Canada) Revenue Growth Rate in Botulism Treatment Business (2016-2021)
Figure 60. Morphotek (U.S.) Revenue Growth Rate in Botulism Treatment Business (2016-2021)
Figure 61. Medytox Solutions (U.S.) Revenue Growth Rate in Botulism Treatment Business (2016-2021)
Figure 62. Lanzhou Institute of Biological Products (China) Revenue Growth Rate in Botulism Treatment Business (2016-2021)
Figure 63. Mentor Corporation and Metabiologics (U.S.) Revenue Growth Rate in Botulism Treatment Business (2016-2021)
Figure 64. Merz Pharma (Germany) Revenue Growth Rate in Botulism Treatment Business (2016-2021)
Figure 65. Allergan (Irish) Revenue Growth Rate in Botulism Treatment Business (2016-2021)
Figure 66. Galderma (Switzerland) Revenue Growth Rate in Botulism Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界のボツリヌス中毒市場規模・現状・予測（2021年-2027年）

Global Botulism Illness Market Size, Status and Forecast 2021-2027
QYR2104Z0960 2021年4月 98Pages
QYResearch社発行の本調査資料では、ボツリヌス中毒のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、抗毒素、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のMSD治療市場規模・現状・予測（2021年-2027年）

Global MSD Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3939 2021年4月 91Pages
QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジ...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の高カルシウム血症治療市場規模・現状・予測（2021年-2027年）

Global Hypercalcemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2989 2021年4月 93Pages
QYResearch社発行の本調査資料では、高カルシウム血症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビスフォスフォネート、糖質コルチコイド、カルシウム模倣薬）、用途別市場規模（軽度高カルシウム血症、中度高カルシウム血症、重度高カルシ...

世界の神経芽細胞腫治療市場規模・現状・予測（2021年-2027年）

Global Neuroblastoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4085 2021年4月 90Pages
QYResearch社発行の本調査資料では、神経芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ...

世界のアフリカトリパノソーマ症治療市場規模・現状・予測（2021年-2027年）

Global African Trypanosomiasis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0157 2021年4月 95Pages
QYResearch社発行の本調査資料では、アフリカトリパノソーマ症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（MS-08、CBL-0137、AN-5568、GNF-6702、その他）、用途別市場規模（研究センター、病院、クリニック、そ...

世界のボツリヌス中毒市場規模・現状・予測（2021年-2027年） Botulism is a rare and potentially fatal illness caused by a toxin produced by the bacterium Clostridium botulinum. The diseasebegins with weakness, blurred vision, feeling tired, and trouble speaking. Market Analysis and Insights: Global Botulism Illness Market The global Botulism Illness market si…
世界のジフテリア治療市場規模・現状・予測（2021年-2027年） Diphtheria is an infectious disease caused by the bacterium Corynebacterium diphtheria causing severe sore throat and fever leading to narrowing of the air passages and barking cough. Diphtheria may also affect the skin, eyes, or genitals and may cause myocarditis, bleeding and kidney problems. The …
世界の髄膜炎菌性疾患治療市場規模・現状・予測（2021年-2027年） Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant …
世界の交流電場腫瘍治療市場規模・現状・予測（2021年-2027年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…
世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年） ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. Market Analysis and Insights: Global Acquired hemophilia A Treatment Market The global Acquired hemophilia A Treatment market size is projected to reach US$ X…